Millions of people around the world are affected by common but poorly defined heterogeneous diseases like dry AMD and linked diseases.
Our SciencePrecision medicine allows us to divide these patients into genetically defined sub-populations for the first time.
Precision MedicineOur ocular platform identifies and prioritizes genetically defined variants that cause disease.
Genetically-Defined AMDThrough a deeper understanding of disease we have identified therapeutic candidates for indications within AMD and linked diseases. Some targets also present in related diseases and help us to grow our pipeline organically.
ProgramsWe’re redefining disease to bring better medicine to millions of patients around the world.
Our Science
We See Disease Differently
Gemini Therapeutics is a precision medicine company focused on the development of new therapies through a deeper understanding of disease. We are sharply focused on dry AMD which is a disease comprised of numerous genetic variants. We also believe that more precisely targeted therapeutics could better address the cause of a patient’s disease.